Physician Wealth Advisors’s Transmedics TMDX Stock Holding History

Physician Wealth Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$403	–	2052
2025 Q2	$403	Buy	+3	New	+$329	﹤0.01%	1754

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Physician Wealth Advisors's TMDX Position: Q3 2025 in Review

Physician Wealth Advisors sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 3 shares — an estimated $403 sold.

Physician Wealth Advisors first reported a position in TMDX in Q2 2025 and held it in 1 quarter. The position peaked at $403 in Q2 2025. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

Physician Wealth Advisors reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
Physician Wealth Advisors sold 3 Transmedics shares in Q3 2025, an estimated $403.
Physician Wealth Advisors first reported a position in Transmedics in Q2 2025 and held it in 1 quarter.
Physician Wealth Advisors's Transmedics position peaked at $403 in Q2 2025.
388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on Physician Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.